Author

Nicole Roth

Institution: CureVac (Germany)

Observed institution: CureVac (Germany)

OpenAlex ID: A5068083949

mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents

2021 · Susanne Rauch, Nicole Roth, et al. · npj Vaccines · 166

Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine

2021 · Makda S. Gebre, Susanne Rauch, et al. · Nature · 135

CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2

2021 · Donata Hoffmann, Björn Corleis, et al. · Nature Communications · 45

Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses

2022 · Nicole Roth, Jacob Schön, et al. · Vaccines · 37

mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response

2024 · Puthupparampil V. Scaria, Nicole Roth, et al. · npj Vaccines · 36

mRNA vaccines induce rapid antibody responses in mice

2022 · Makda S. Gebre, Susanne Rauch, et al. · npj Vaccines · 32

Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models

2023 · Björn Corleis, Donata Hoffmann, et al. · Nature Communications · 26

Immunogenicity and protective activity of mRNA vaccine candidates against yellow fever virus in animal models

2023 · Lex G. Medina-Magües, Janine Mühe, et al. · npj Vaccines · 19

Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models

2023 · Nicole Roth, Janina Gergen, et al. · Vaccines · 10

mRNA vaccine-induced IgG mediates nasal SARS-CoV-2 clearance in mice

2024 · Charlie Fricke, Lorenz Ulrich, et al. · Molecular Therapy — Nucleic Acids · 1

Works count: 10

Citation count: 507

H-index: 9

I10-index: 9